ZTS Zoetis Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZTS

Price (delayed)

$173.98

Market cap

$80.09B

P/E Ratio

36.55

Dividend/share

$1.45

EPS

$4.76

Enterprise value

$85.11B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
Zoetis's quick ratio has increased by 33% YoY
Zoetis's EPS has increased by 8% YoY and by 7% QoQ
The P/E is 10% lower than the 5-year quarterly average of 40.5 but 4.4% higher than the last 4 quarters average of 35.0
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.zoetis.com/
Peers: LLY PFE MRK PAHC

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
460.32M
Market cap
$80.09B
Enterprise value
$85.11B
Valuations
Price to earnings (P/E)
36.55
Price to book (P/B)
17.38
Price to sales (P/S)
9.77
EV/EBIT
27.74
EV/EBITDA
24.02
EV/Sales
10.35
Earnings
Revenue
$8.22B
EBIT
$3.07B
EBITDA
$3.54B
Free cash flow
$1.29B
Per share
EPS
$4.76
Free cash flow per share
$2.79
Book value per share
$10.01
Revenue per share
$17.8
TBVPS
$21.18
Balance sheet
Total assets
$13.75B
Total liabilities
$9.13B
Debt
$6.75B
Equity
$4.63B
Working capital
$4.41B
Liquidity
Debt to equity
1.46
Current ratio
3.5
Quick ratio
1.72
Net debt/EBITDA
1.42
Margins
EBITDA margin
43.1%
Gross margin
70.1%
Net margin
26.9%
Operating margin
37.3%
Efficiency
Return on assets
15.8%
Return on equity
48.7%
Return on invested capital
25.2%
Return on capital employed
25.6%
Return on sales
37.3%
Dividend
Dividend yield
0.83%
DPS
$1.45
Payout ratio
30.5%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
-0.02%
1 week
-1.53%
1 month
-9.75%
1 year
15.26%
YTD
18.72%
QTD
1.03%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$8.22B
Gross profit
$5.77B
Operating income
$3.06B
Net income
$2.21B
Gross margin
70.1%
Net margin
26.9%
Zoetis's operating income has increased by 10% YoY and by 7% QoQ
The operating margin has increased by 7% YoY and by 6% from the previous quarter
The net income has grown by 7% from the previous quarter and by 6% YoY
The net margin rose by 5% QoQ and by 3.1% YoY

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
ZTS P/E details
P/E
36.55
P/B
17.38
P/S
9.77
EV/EBIT
27.74
EV/EBITDA
24.02
EV/Sales
10.35
The P/E is 10% lower than the 5-year quarterly average of 40.5 but 4.4% higher than the last 4 quarters average of 35.0
Zoetis's EPS has increased by 8% YoY and by 7% QoQ
The stock's price to book (P/B) is 13% less than its 5-year quarterly average of 19.9 but 7% more than its last 4 quarters average of 16.2
ZTS's equity is up by 2.9% since the previous quarter
ZTS's price to sales (P/S) is 7% higher than its last 4 quarters average of 9.1 but 3.3% lower than its 5-year quarterly average of 10.1
ZTS's revenue is up by 2.8% YoY

Efficiency

How efficient is Zoetis business performance
The company's return on equity rose by 8% YoY and by 7% QoQ
ZTS's return on assets is up by 7% since the previous quarter and by 4.6% year-on-year
Zoetis's return on sales has increased by 7% YoY and by 6% QoQ
ZTS's ROIC is up by 2% QoQ

Dividends

What is ZTS's dividend history
Dividend details
DPS
$1.45
Dividend yield
0.83%
Payout ratio
30.5%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 51% greater than its total liabilities
The company's current ratio has surged by 61% YoY and by 7% QoQ
Zoetis's quick ratio has increased by 33% YoY
The debt is 46% higher than the equity
Zoetis's debt to equity has decreased by 2.7% QoQ
ZTS's equity is up by 2.9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.